Skip to Main Content

A look ahead to the next week in biotech:

Earnings season is approaching, which means once again, analysts will get the opportunity to punch “star-1” on their telephone keypads to ask the management team at Gilead Sciences, “Who are you going to buy?”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!